Heart failure (HF) is a rapidly growing public health issue with an estimated prevalence of >37.7 million individuals globally. HF is a shared chronic phase of cardiac functional impairment secondary to many aetiologies, and patients with HF experience a range of symptoms that affect their quality of life, including dyspnoea, fatigue, poor exercise tolerance and fluid retention.

The burden of HF will continue to rise, due to population aging, population growth and improved treatment of HF and other cardiovascular disorders. As a result, clinicians will be increasingly challenged to develop treatment plans and care systems that reduce the high levels of morbidity and mortality experienced by these patients, both from their HF and other comorbidities.

Related Articles


Why Did COAPT Win While MITRA-FR Failed? Defining the Appropriate Patient…

Kimberly Atianzar, Ming Zhang, Zachary Newhart,

Citation: Interventional Cardiology Review 2019;14(1):45–7

Percutaneous Treatment of Coronary Chronic Total Occlusions Part 1:…

Alfredo Galassi, Aaron Grantham, David Kandzari,

Citation: Interventional Cardiology Review 2014;9(3):195–200

Alcohol Septal Ablation for the Treatment of Hypertrophic Obstructive…

Constantinos O’Mahony, Saidi Mohiddin, Charles Knight,

Citation: Interventional Cardiology Review 2014;9(2):108-14

Review of Data and Discussion - Who Should Undergo Patent Foramen Ovale…

Amit Bhan, Brian Clapp,

Citation: Interventional Cardiology Review 2014;9(2):115–20